New research at the Mailman School of Public Health finds reinfections of COVID-19 are not uncommon, and genetic factors may be a greater determinant of an infection's severity.
Two cardiology fellows at Columbia University Irving Medical Center are studying why blood clot risks in COVID-19 patients are greater than in other severely ill patients and are working with experts from around the world to create treatment guidelines.
The Mailman School of Public Health and the University of Chile has launched a year-long study of COVID-19 frontline health care workers in more than 20 countries around the world.
Latest forecasts for uptick in cases and deaths tied to easing of stay-at-home orders in 25 U.S. states.
A newly published paper by researchers at the Mailman School of Public Health cites reports of a recent surge in domestic violence in China as calls to abuse hotlines and visits to support websites in New York City have spiked.
A study of nearly 1,400 patients with moderate to severe COVID-19 disease at a single New York hospital found that patients who received the drug fared no better than patients who did not receive the drug.
Responses will allow researchers to understand the impact on those most directly affected by the crisis and learn how to best address their needs.
Based on this new study from researchers at Columbia University Irving Medical Center, a clinical trial to test the effect of reducing testosterone in COVID-19 patients is set to begin at three Veterans Affairs hospitals in New York City, Los Angeles, and the Seattle region.
New projections from Columbia's Mailman School of Public Health find that delays in reimplementing social distancing following a relaxation of control measures could result in a stronger rebound of COVID-19 infections and deaths.